FDA inspection
Amgen Singapore Manufacturing Pte Ltd: FDA inspection ending May 25, 2018
FDA inspection 1060510 · No Action Indicated (NAI) · Singapore
Key facts
| Inspection ID | 1060510 |
|---|---|
| Firm | Amgen Singapore Manufacturing Pte Ltd |
| FEI number | 3011255424 |
| Address | 1 Tuas View Drive |
| City | Singapore |
| Country | Singapore |
| Fiscal year | 2018 |
| Inspection end date | May 25, 2018 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data